Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Blood Advances|February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawalMark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Molecular Ecology|October 11, 2011
Phylogeography and bindin evolution in Arbacia, a sea urchin genus with an unusual distributionH A Lessios, S Lockhart, R Collin, et al.
Leukemia & Lymphoma|October 14, 2024
HMA/VEN treatment modifications and associated outcomes in <i>IDH</i>-mutant AMLKuo-Kai Chin, Andriy Derkach, Christopher Famulare, et al.
Plos Genetics|September 21, 2022
The germ cell-specific RNA binding protein RBM46 is essential for spermatogonial differentiation in miceNatoya J Peart, Taylor A Johnson, Sungkyoung Lee, et al.
Pediatric Blood & Cancer|March 14, 2014
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemiaCatherine McGuinn, Mark B Geyer, Zhezhen Jin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantationErin Qualter, Prakash Satwani, Angela Ricci, et al.
Haematologica|October 15, 2020
Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemiaMark B Geyer, Ellen K Ritchie, Arati V Rao, et al.
JCI Insight|April 3, 2019
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLLMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.
Cancer Immunology Research|May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential SynergyEric L Smith, Sham Mailankody, Mette Staehr, et al.
Blood Advances|June 18, 2026
Outcomes of Adolescents and Young Adults with AML Treated on Pediatric vs Adult ProtocolsBaher Krayem, Jeetayu Biswas, Andriy Derkach, et al.
Pageof 14